세계의 폴리-L-젖산(PLLA) 필러 시장 - 규모, 점유율, 동향 분석 보고서 : 용도별, 최종 용도별, 지역별 부문 예측(2025-2030년)

Poly-L-lactic Acid Filler Market Growth & Trends:

The global poly-l-lactic acid filler market size is estimated to reach USD 764.8 million by 2030, registering a CAGR of 10.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market growth are the rising demand for minimally invasive cosmetic procedures, the growing aging population, and technological advancements. According to the ASPS article published in September 2023, there has been a notable rise in the number of male patients pursuing minimally invasive cosmetic surgeries, with over 1.5 million men undergoing these procedures in 2022. This marks a 253 percent increase since 2019. These aspects fuel the growth of the market.

Moreover, technological advancements of poly-l-lactic acid (PLLA) filler is anticipated to boost the market growth. According to the NCBI article published in June 2022, initially approved for correcting nasolabial folds and other facial wrinkles, PLLA fillers are now also used off-label for body rejuvenation. This broader application highlights the flexibility of PLLA fillers, which can address various aesthetic issues beyond the face, such as volume loss, skin laxity, and wrinkles in different body areas, including the neck. A significant technological advancement of PLLA fillers is their capacity to stimulate collagen production, resulting in long-term aesthetic benefits. Research indicates an increase in collagen type-I at 3 and 6 months post-PLLA injections, establishing PLLA fillers as a distinct class of collagen stimulators with prolonged effects. This characteristic makes PLLA fillers popular for their ability to deliver lasting skin quality and volume improvements.

The growing adoption of PLLA fillers among healthcare professionals and patients fuels market growth. According to the NCBI article published in March 2024, scientific research has confirmed the effectiveness of PLLA fillers, which stimulate collagen production and are gradually broken down into carbon dioxide and water. Even after the PLLA fully degrades, the newly formed collagen fibers can continue to function for an extended period, highlighting the fillers' long-lasting benefits and safety.

Poly-L-lactic Acid Filler Market Report Highlights:

• The face segment held the largest share of over 44.2% in 2024, owing to the rising popularity of facial rejuvenation procedures, technological advancements in fillers, and the expanding middle-aged and elderly population.
• The cosmetic surgery centers segment held the largest share of 44.9% in 2024, due to the presence of a higher number of these centers offering invasive procedures.
• North America dominated the global market with a revenue share of 36.51% in 2024, owing to advanced healthcare infrastructure, increasing adoption of aesthetic procedures, huge research and development activities, and continuous technological advancements in cosmetic treatments.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. End-use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application Segment
  • 2.2.2. End-use Segment
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Poly-L-lactic Acid (PLLA) Filler Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for minimally invasive cosmetic procedures
    • 3.2.1.2. Aging population and rising focus on anti-aging solutions
    • 3.2.1.3. Technological advancements and product innovations
    • 3.2.1.4. Growing awareness and acceptance of cosmetic enhancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent Regulatory Policies
• 3.3. Poly-L-lactic Acid (PLLA) Filler Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Poly-L-lactic Acid (PLLA) Filler Market: Application Estimates & Trend Analysis

• 4.1. Poly-L-lactic Acid (PLLA) Filler Market: Application Dashboard
• 4.2. Poly-L-lactic Acid (PLLA) Filler Market: Application Movement Analysis
• 4.3. Poly-L-lactic Acid (PLLA) Filler Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 4.4. Face
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Neck
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Abdomen
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Knees
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.8. Thighs
  • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Poly-L-lactic Acid (PLLA) Filler Market: End-use Estimates & Trend Analysis

• 5.1. Poly-L-lactic Acid (PLLA) Filler Market: End-use Dashboard
• 5.2. Poly-L-lactic Acid (PLLA) Filler Market: End-use Movement Analysis
• 5.3. Poly-L-lactic Acid (PLLA) Filler Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 5.4. Medspas
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Cosmetic Surgery Centers
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Poly-L-lactic Acid (PLLA) Filler Market: Regional Estimates & Trend Analysis by Country, Application, and End-use

• 6.1. Global Poly-L-lactic Acid (PLLA) Filler Market: Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Regulatory framework/ reimbursement structure
    • 6.3.4.3. Competitive scenario
    • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3. Japan
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.7. South Korea
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.3. South Africa
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
  • 7.1.1. Key company market share analysis, 2023
  • 7.1.2. Galderma
    • 7.1.2.1. Company overview
    • 7.1.2.2. Financial performance
    • 7.1.2.3. End-use benchmarking
    • 7.1.2.4. Strategic initiatives
  • 7.1.3. GANA R&D
    • 7.1.3.1. Company overview
    • 7.1.3.2. Financial performance
    • 7.1.3.3. End-use benchmarking
    • 7.1.3.4. Strategic initiatives
  • 7.1.4. Sinclair Pharma
    • 7.1.4.1. Company overview
    • 7.1.4.2. Financial performance
    • 7.1.4.3. End-use benchmarking
    • 7.1.4.4. Strategic initiatives
  • 7.1.5. PRP Science
    • 7.1.5.1. Company overview
    • 7.1.5.2. Financial performance
    • 7.1.5.3. End-use benchmarking
    • 7.1.5.4. Strategic initiatives
  • 7.1.6. EPRUI Biotech
    • 7.1.6.1. Company overview
    • 7.1.6.2. Financial performance
    • 7.1.6.3. End-use benchmarking
    • 7.1.6.4. Strategic initiatives
  • 7.1.7. Hyamax
    • 7.1.7.1. Company overview
    • 7.1.7.2. Financial performance
    • 7.1.7.3. End-use benchmarking
    • 7.1.7.4. Strategic initiatives